Advances in pediatrics
-
Advances in pediatrics · Jan 2008
ReviewCystic fibrosis: a review of pulmonary and nutritional therapies.
In summary, there is a significant interplay between the pulmonary manifestations and nutritional status of CF patients. The advances in CF clinical care in the past 2 decades are mainly attributed to anti-infective therapy as well as aggressive nutritional management. Currently, there are multiple therapeutic agents that are in clinical trial that target either the underlying CFTR defect or the downstream effects of CFTR. The broad spectrum of therapeutic agents being studied as well as the advances in therapies that target the underlying CFTR defect are exciting, making it likely that at least one of the treatments will make a major difference in how we will treat CF in the future.
-
SUMMARY MHI is a common disorder in t he pediatric population. While most children recover uneventfully, a small percentage has persistence of symptoms and long-term sequelae. Determining the optimal timing for return to play can be difficult, but adherence to guidelines may reduce the risk of compounding the injury.